Xenon: A review of its anaesthetic and pharmacological properties

Applied Cardiopulmonary Pathophysiology

Volumn 6, Issue 2, 1996, Pages 95-103

  Giunta, Francesco ^a   Natale, Gianfranco ^b   Turco, Monica Del ^b   Tacca, Mario Del ^b  

^a Dipartimento di Chirurgia   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Anaesthetic gases; Inert gases; Xenon

Indexed keywords

ANESTHETIC AGENT; NITROUS OXIDE; XENON;

ANESTHESIA; BREATHING APPARATUS; COMPUTER SYSTEM; DRUG COST; GAS FLOW; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REBREATHING; REVIEW;

EID: 0030474551     PISSN: 09205268     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. CRC. Handbook of chemistry and physics. A ready-reference hook of chemical and physical data. Weast RC, editor. 67th edition. Boca Raton, Florida, USA: CRC Press. Inc., 1987.
2. Lachmann B. Armbruster S, Schairer W. Landstra M, Trouwborst A. Van Daal G-J. Kusuma A, Erdmann W. Safety and efficacy of xenon in routine use as an inhalational anaesthetic. Lancet 1990; 335: 1413-5.
3. Lane G A. Nahrwold ML. Tait AR, Taylor-Bush M, Cohen PJ. Anesthetics as teratogens: nitrous oxide is fetotoxic. xenon is not. Science 1980; 210: 899-901.
4. Boomsma F, Rupreht J. Man In T Veld AJ, De Jong FH. Dzoljic M. Lachmann B. Haemodynamic and neurohumoral effects of xenon anaesthesia. A comparison with nitrous oxide. Anaesthesia 1990; 45: 273-8.
5. Halsey MJ. Potency and physical properties of inhalational anaesthetics. In: Nunn JF, Utting JE. Brown BR Jr (eds) General anaesthesia. Fifth edition. London: Butterworths. 1989. pp7-18.
6. Kennedy RR. Stokes JW. Downing P. Anaesthesia and the 'inert' gases with special reference to xenon. Anaesth Intens Care 1992; 20: 66-70.
7. Mapleson WW. Pharmacokinetics of inhalational anaesthetics. In: Nunn JF, Utting JE. Brown BR Jr (eds) General anaesthesia. Fifth edition. London: Butterworths. 1989, pp 44-59.
8. Lawrence JH, Loomis WF. Tobias CA, Turpin FH. Preliminary observations on the narcotic effect of xenon with a review of values for solubilities of gases in water and oils. J Physiol 1946; 105: 197-204.
9. Braken A. Bures THS. Newland DS. A trial of xenon as a non-explosive anaesthetic. Anaesthesia 1956; 11: 40-9.
10. Cullen SC. Gross EG. The anesthetic properties of xenon in animals and human beings, with additional observations on krypton. Science 1951; 113: 580-2.
11. Domino EF, Gottlieb SF, Brauner RW, Cullen SC. Featherstone RM. Effects of xenon at elevated pressures in the dog. Anesthesiology 1964; 25: 43.
12. Eger El, Brandstater B. Saidman LJ, Regan MJ. Severinghaus JW. Munson ES. Equipotent alveolar concentration of methoxyflurane, halothane, diethyl ether, fluroxene, cyclopropane, xenon and nitrous oxide in the dog. Anesthesiology 1965; 26: 771-7.
13. Pittinger CB, Moyers J. Cullen SC, Featherstone RM, Gross EG. Clinicopathologic studies associated with xenon anesthesia. Anesthesiology 1953; 14: 10-7.
14. Cullen SC. Eger El, Cullen BF. Gregory P. Observations on the anesthetic effect of the combination of xenon and halothane. Anesthesiology 1969; 31: 305-9.
15. Luttropp HH, Thomasson R, Dahm S. Persson J. Werner O. Clinical experience with minimal flow xenon anesthesia. Acta Anaesthesiol Scand 1994; 38: 121-5.
16. Luttropp HH. Romner B, Perhag L, Eskilsson J, Fredriksen S. Werner O. Left ventricular performance and cerebral haemodynamics during xenon anaesthesia. A transoesophageal echocardiography and transcranial Doppler sonography study. Anaesthesia 1993; 48: 1045-9.
17. Burov NE, Ivanov GG, Ostapchenko DA, Dzhabarov DA, Kornienko Llu, Shulunov MV. Hemodynamics and function of the myocardium during xenon anesthesia. Anesteziol Reanimatol 1993; 5: 57-9.
18. Burov NE, Dzhabarov DA, Ostapchenko DA, Kornienko L, Shulunov MV. Clinical stages and subjective sensations in xenon anesthesia. Anesteziol Reanimatol 1993; 4: 7-11.
19. Yagi M, Mashimo T, Kawaguchi T, Yoshiya I. Analgesic and hypnotic effects of subanaesthetic concentrations of xenon in human volunteers: comparison with nitrous oxide. Br J Anaesth 1995; 74: 670-3.
20. James PB. Xenon for anaesthesia [letter]. Lancet 1990; 336: 324.
21. Nunn JF, Halsey MJ. Xenon in anaesthesia [letter]. Lancet 1990; 336: 112-3.
22. Power KJ. Does xenon deserve a prominent place in anaesthetic practice? [letter]. Anaesthesia 1990; 45: 783-4.
23. Otteni JC. Xenon, anesthesiquc par inhalation: un comeback? Ann Fr Anesth Reanim 1991; 10: 490-1.
24. Halsey MJ. Molecular mechanisms of anaesthesia. In: Nunn JF, Utting JE, Brown BR Jr (eds) General anaesthesia. Fifth edition. London: Butterworths, 1989, pp 19-29.
25. Miller KW, Paton WDM, Smith RA, Smith EB. The pressure reversal of general anaesthesia and the critical volume hypothesis. Mol Pharmacol 1973; 9: 131-43.
26. Wann KT, Macdonald AG. Actions and interactions of high pressure and general anaesthetics. Prog Neurobiol 1988; 30: 271-307.
27. Trudell JR, Hubbel WL, Cohen EN. The effects of two inhalation anesthetics on the order of spin-labeled phospholipid vesicles. Biochim Biophys Acta 1973; 291: 321-7.
28. Franks NP, Lieb WR. What is the molecular nature of general anaesthetic target sites? Trends Pharmacol Sci 1987; 8: 169-74.
29. 129Xe-NMR study. Biochim Biophys Acta 1994; 1193: 186-98.
30. Andersen OS. Ion movement through gramicidin A channels. Single-channel measurements at very high potentials. Biophys J 1983; 41: 119-33.
31. Finkelstein A, Rosenberg PA. Membrane transport processes. In: Stevens CF, Tsien RW (eds) Vol 3. New York: Raven Press, 1979, pp 73-88.
32. Seoh SA, Busath D. The permeation properties of small organic cations in gramicidin-A channels. Biophys J 1993; 64: 1017-28.
33. Franks JJ, Horn J-L, Janicki PK, Singh G. Halothane, isoflurane, xenon, and nitrous oxide inhibit calcium ATPase pump activity in rat brain synaptic plasma membranes. Anesthesiology 1995; 82: 108-17.
34. 2+-ATPase pump activity in cultured C6 glioma cells by halothane and xenon. Life Sci 1995; 56: PL 219-24.
35. 2+ -ATPase activity in rats with streptozocin-induced diabetes: association with reduced anesthetic requirements. Life Sci 1994; 55: PL 359-64.
36. Franks JJ, Sastry BVR, Suiter MJ, England RE. Halothane and isoflurane alter phospholipid transmethylation in rat brain synaptosomes. Anesthesiology 1990; 73: 984-9.
37. 2+-ATPase pumping, and enhanced brain synaptic plasma membrane phospholipid methylation in diabetic rats: effects of insulin. Life Sci 1995; 56: PL 357-63.
38. Schiltz M, Fourme R, Broutin I, Prange T. The catalytic site of serine proteinases as a specific binding cavity for xenon. Structure 1995; 3: 309-16.
39. Layzer RB. Myeloneuropathy after prolonged exposure to nitrous oxide. Lancet 1978; ii: 1227-30.
40. Spence AA. Environmental pollution by inhalation anaesthetics. Br J Anaesth 1987; 59: 96-103.
41. Yao L, Bandres J, Nemoto EM, Boston R, Darby JM, Yonas H. Effect of 33% xenon inhalation on whole-brain blood flow and metabolism in awake and fentanyl-anesthetized monkeys. Stroke 1992; 23: 69-74.
42. Darby JM, Yonas H, Pentheny SL, Marion DW. Intracranial pressure response to stable xenon inhalation in patients with head injury. Surg Neurol 1989; 32: 343-5.
43. Hartmann A, Dettmers C, Schuier FJ, Wassman HD, Schumacher HW. Effect of stable xenon on regional cerebral blood flow and the electroencephalogram in normal volunteers. Stroke 1991; 22: 182-
44. Junck L, Dhawan V, Thaler HT, Rottenberg DA. Effects of xenon and krypton on regional cerebral blood flow in the rat. J Cereb Blood Flow Metab 1985; 5: 126-32.
45. Segawa H, Wakai S, Tamura A, Yoshimasu N, Nakamura O, Ohta M. Computed tomographic measurement of local cerebral blood flow by xenon enhancement. Stroke 1983; 14: 356-62.
46. Yonas H, Good WF, Gur D, Wolfson SK Jr, Latchaw RE, Good BC, Leanza R, Miller SL. Mapping cerebral blood flow by xenon-enhanced computed tomography: clinical experience. Radiology 1984; 152: 435-42.
47. Yonas H, Wolfson SK, Gur D, Latchaw RE, Good WF, Leanza R, Jackson DL, Jannetta PJ, Reinmuth OM. Clinical experience with the use of xenon-enhanced CT blood flow mapping in cerebral vascular disease. Stroke 1984; 15: 443-50.
48. Luttropp HH, Rydgren G, Thomasson R, Werner O. A minimal-flow system for xenon anesthesia. Anesthesiology 1991; 75: 896-902.
49. Rupreht J. Reply to Power KJ. Does xenon deserve a prominent place in anaesthetic practice? [letter]. Anaesthesia 1990; 45: 784.
50. Corbally MT, Brennan MF. Noninvasive measurement of regional blood flow in man. Am J Surg 1990; 160: 313-21.
51. Drayer BP, Wolfson SK, Reinmuth OM, Dujovny M, Boehnke M, Cook EE. Xenon-enhanced CT for analysis of cerebral integrity, perfusion and blood flow. Stroke 1978; 9: 123-30.
52. Bouma GJ, Muizelaar JP. Evaluation of regional cerebral blood flow in acute head injury by stable xenon-enhanced computerized tomography. Acta Neurochir 1993; 59 (Suppl): 34-40.
53. Gobbel GT, Cann CE, Fike JR. Comparison of xenon-enhanced CT with ultrafast CT for measurement of regional cerebral blood flow. Am J Neuroradiol 1993; 14: 543-50.
54. Schröder ML, Muizelaar JP. Monitoring of regional cerebral blood flow (CBF) in acute head injury by thermal diffusion. Acta Neurochir 1993; 59 (Suppl): 47-9.
55. Nambu K, Suzuki R, Hirakawa K. Cerebral blood flow: measurement with xenon-enhanced dynamic helical CT. Radiology 1995; 195: 53-7.
56. Mori I. Computerized tomographic apparatus utilizing a radiation source. US Patent 4,630,202, 1986.
57. Forrest FC, Randalls PB, Barnas GM, Hoff BH, Oletsky J, Mackenzie CF. Transfer of gas from the acinus during continuous flow and intermittent positive pressure ventilation. Respir Physiol 1994; 95: 147-54.
58. Oraevsky AA. Jacques SL, Pettit GH, Saurbrey RA, Tittel FK, Nguy JH. Henry PD. XeCl laser-induced fluorescence of atherosclerotic arteries. Spectral similarities between lipid-rich lesions and peroxidized lipoproteins. Circ Res 1993; 72: 84-90.
59. Stabholz A. Neev J, Liaw LH, Stabholz A. Khayut A, Tora-binejad M. Sealing of human dentinal tubules by XeCl 308-nm excimer laser. J Endod 1993; 19: 267-71.